Russell Investments Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86K | Sell |
166
-35,531
| -100% | -$399K | ﹤0.01% | 3598 |
|
|
2025
Q1 | $163K | Sell |
35,697
-40,341
| -53% | -$184K | ﹤0.01% | 2646 |
|
|
2024
Q4 | $429K | Sell |
76,038
-29,355
| -28% | -$166K | ﹤0.01% | 2322 |
|
|
2024
Q3 | $510K | Buy |
105,393
+22,159
| +27% | +$107K | ﹤0.01% | 2271 |
|
|
2024
Q2 | $406K | Buy |
83,234
+82,820
| +20,005% | +$404K | ﹤0.01% | 2272 |
|
|
2024
Q1 | $5.5K | Buy |
414
+391
| +1,700% | +$5.19K | ﹤0.01% | 2930 |
|
|
2023
Q4 | $321 | Buy |
+23
| New | +$321 | ﹤0.01% | 3152 |
|
|
2023
Q3 | – | Sell |
-23
| Closed | -$431 | – | 3631 |
|
|
2023
Q2 | $431 | Hold |
23
| – | – | ﹤0.01% | 3371 |
|
|
2023
Q1 | $332 | Buy |
+23
| New | +$332 | ﹤0.01% | 3215 |
|